NewLeaf Symbiotics

Categories
Founded

2012

Leadership
  • Brent Smith, CEO
  • Steve Kahn, Co-Founder
Headquarters

St Louis, MO

Website

newleafsym.com

S2G North Star Interim Outcomes Jump to footnote 1
  • Increased availability, accessibility, and/or affordability of healthier foods and nutrition-based solutions
UN SDG Alignment Jump to footnote 2
  • Zero Hunger
NewLeaf Symbiotics is a biological technology provider known as the pioneer and global leader of Pink-Pigmented Facultative Methylotrophs (PPFMs) and methanotrophs, a closely related microbe.

The company has nine technologies on ten crops developed over the last decade and has a pipeline backed by more than 250 patents focused on sustainable and yield-based outcomes in crop production. Ranging from row crops to specialty operations, NewLeaf is dedicated to a science-led, performance-driven and data-backed approach that delivers results to its partners and the growers they support. 

Open Positions

Insights

News

Footnotes

  1. S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.

  2. UN Sustainable Development Goal (SDG) alignment has been obtained from portfolio companies, internally collected data by S2G and/​or sources outside S2G, and could prove to be incomplete or inaccurate and is current only as of July 31, 2026. S2G makes no representations as to the accuracy or completeness of the information obtained from such portfolio companies and/​or sources and neither S2G nor any of its affiliates takes any responsibility for, and has not independently verified, any such information.